A switch from twice-daily exenatide to once-daily liraglutide further improves glycaemic control in patients with type 2 diabetes on oral agents Article

Web of Science: 000269262400003
Industry Collaboration International Collaboration

Cited authors

  • Buse, J.; Sesti, G.; Schmidt, W. E.; Montanya, E.; Xu, Y.; Chang, C.; Blonde, L.; Rosenstock, J.

Authors

Publication date

  • 2009

Published in

International Standard Serial Number (ISSN)

  • 0012-186X

Start page

  • S7

End page

  • S8

Volume

  • 52